Coordination Pharmaceuticals

About:

Coordination Pharmaceuticals is a drug development company that aims to address unmet medical needs and improve patient care.

Website: http://www.coordinationpharma.com/

Top Investors: TF Capital

Description:

Coordination Pharmaceuticals is a drug development company that aims to address unmet medical needs and improve patient care. The NCP platform was pioneered by the lab of Professor Wenbin Lin at the University of Chicago. As a versatile technology platform, NCP components can be purposefully chosen to synergize with and enhance currently existing therapies. CPI products are especially potent in combination with checkpoint blockade inhibitors by increasing T cell infiltration into lowly immunogenic solid tumors.

Total Funding Amount:

$18M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Elk Grove Village, Illinois, United States

Founded Date:

2017-01-01

Contact Email:

lin(AT)coordinationpharma.com

Founders:

James Franck

Number of Employees:

1-10

Last Funding Date:

2021-09-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai